Read below for travel health advice on diseases and special needs from the MDtravelhealth channel.
Anthrax is caused by a bacterium known as Bacillus anthracis, which infects grazing herbivores, chiefly cattle, sheep, goats, and horses. When exposed to oxygen, the organism forms spores, which are resistant to heat, sunlight, and dessication and can survive for decades. Anthrax usually occurs in those handling infected animals or their products, including hides, hair, wool, or flesh. Spores are introduced through a break in the skin, leading to a small raised area on the skin which ulcerates and turns black. (The name anthrax is derived from the Greek word for coal.) When untreated, the illness may be complicated by high fevers, swelling of the area around the ulcer, enlargement of the regional lymph nodes, infection of the bloodstream, and death. However, the cure rate is high when appropriate antibiotics are given.
Rarely, inhalation of anthrax spores causes inhalational anthrax, known historically as Woolsorters' Disease, which progresses rapidly and is often fatal despite treatment. Inhalational anthrax begins with non-specific flu-like symptoms, including fever, malaise, fatigue, dry cough, and chest discomfort, followed by the abrupt onset of respiratory distress, cyanosis (purplish color), profuse sweating, confusion, and shock. The chief finding is hemorrhagic mediastinitis (bloody inflammation of the lymph nodes in the center of the chest). The chest film may show a widened mediastinum or effusions, but generally does not show infiltrates. Chest CT is often helpful in assessing the mediastinal lymph nodes, especially if plain chest films are non-diagnostic. The course is frequently complicated by hemorrhagic meningitis (blood in the spinal fluid).
The diagnosis of an anthrax skin infection is generally made by culturing the skin lesion, though cultures are usually negative after antibiotics have been given. Immunohistochemical staining of tissue specimens obtained from the edge of the skin lesion may be helpful. The diagnosis of inhalational anthrax is generally confirmed by positive blood cultures. The microbiology laboratory should be alerted that anthrax is to be ruled out, because most Bacillus species found in blood cultures are contaminants. If blood cultures are negative, serum and other body fluids may be sent for PCR. A nasal swab for culture or direct fluorescent antigen may be positive shortly after exposure to anthrax, but may be negative by the time of clinical illness.
Pending final culture results, initial therapy for inhalational anthrax should consist of cipro 400 mg every 12 hours or doxycycline 100 mg every 12 hours by vein, in combination with a second antibiotic. For children, the recommended dosages are cipro 5-7.5 mg/kg every 12 hours and doxycycline 2.5 mg/kg every 12 hours, up to the adult dosages. Data are limited, but other quinolones are likely to be equally effective. Options for the second antibiotic include rifampin, vancomycin, imipenem, chloramphenicol, penicillin and ampicillin, clindamycin, and clarithromycin (Biaxin), all of which have shown activity against the strains of anthrax recently isolated in the United States. After clinical improvement, treatment may be completed with either one or two drugs. Therapy should be continued for a total of 60-100 days. Penicillin should not be used alone for inhalational anthrax, even if the strain appears susceptible, because laboratory studies suggest the organism may become resistant during treatment. Steroids may be used as adjunct therapy in cases with extensive edema, respiratory compromise, or meningitis. Anthrax of the skin is usually treated with cipro or doxycycline alone. If the illness is complicated by extensive swelling or severe toxicity, a second antibiotic should be added, as for inhalational anthrax.
Because of potential adverse effects of prolonged use of cipro or doxycycline in children and pregnant women, penicillin or amoxicillin may be substituted for cipro or doxycycyline once the strain has been shown to be susceptible to penicillin and the patient is clinically improving. In pregnant women, cipro is thought to be preferable to doxycycline, because the latter drug may be associated with an increased risk of bone and dental abnormalities in the developing fetus.
Those exposed to anthrax spores should be promptly started on cipro 500 mg twice daily or doxycycline 100 mg twice daily by mouth, to be continued for 60 days. If the strain is found to be susceptible to penicillin, high-dose penicillin or amoxicillin may be given.
Anthrax vaccine may be effective, but supplies are limited and have been reserved for military personnel, laboratory workers, and those who have been exposed to anthrax spores. For pre-exposure immunization, a total of five intramuscular injections are recommended on day 0, week 4, and months 6, 12, and 18, followed by annual boosters. For previously unvaccinated persons who have been exposed to anthrax spores, a total of three subcutaneous injections are recommended at 0, 2, and 4 weeks, in conjunction with a 60 day course of antibiotics.
For the most recent recommendations on the use of anthrax vaccine, see
Use of Anthrax Vaccine in the United States - Recommendations of the Advisory Committee on Immunization Practices, 2009 on the CDC website.
Anthrax is not transmissible from person-to-person. In the hospital, standard barrier precautions should be adequate (i.e. masks are not necessary once the diagnosis is confirmed).
From the World Health Organization (WHO)
Guidance on anthrax: frequently asked questions
Guidelines for the Surveillance and Control of Anthrax in Humans and Animals
From the Centers for Disease Control (CDC)
Use of Anthrax Vaccine in the United States - Recommendations of the Advisory Committee on Immunization Practices, 2009
Notice to Readers: Use of Anthrax Vaccine in Response to Terrorism: Supplemental Recommendations of the Advisory Committee on Immunization Practices
Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
Update: Investigation of Bioterrorism-Related Anthrax and Adverse Events from Antimicrobial Prophylaxis
Notice to Readers: Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis
Notice to Readers: Update: Interim Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children with Anthrax
Notice to Readers: Additional Options for Preventive Treatment for Persons Exposed to Inhalational Anthrax
Anthrax of the Gastrointestinal Tract
From the New England Journal of Medicine (NEJM)
Anthrax (review article)
From Emerging Infectious Diseases
Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax, D. Bell
Anthrax of the Gastrointestinal Tract, T. Sirisanthana and A. E. Brown
Do you have any comments on this resource page? We want to tell the Red Planetter community about this condition or advice.
You don't need an account or have to sign up or anything!
Is there anything missing that you know about? Or can you offer any insightful tips from your experience?
You can earn Reputation score by joining our community and also enrol on the TravelTip$ program and get paid for good advice by other travellers.
If you are not logged in, or choose to make the drop box anonymously you can tell the community honestly what you seen without any concern. Please send images or other evidence to support your claims.
The MDtravelhealth channel is a source of travel health information for travellers, written by medical professionals.
The MDtravelhealth channel relies on medical professionals from all over the world to maintain the Travel Health Information on these pages.
Topic Tags are what bind the Red Planet Travel site together, and are very important.
This place has been tagged:
Ask any travel related question or help others with your experience and earn Reputation Score and become a valued member of our community.
Before you apply read about the Medical Professionals Roles on Red Planet TravelYou need to be logged in and have applied to MDth channel to contribute to this page.
We are looking to grow the information on this site, if you have something to contribute to any page then we'd like to hear from you.
What's more you can now earn money (paid direct via Paypal) for writing descriptions about places you know.
You will need to tell other members about yourself and your relevant knowledge and experience about what you want to contribute about.
Look below for some example page types, and types of people whose views on a place might be useful to know.
Page Type: Hotel
Tell us your job, knowledge, experience..
My Experience: Doctor
If you are the owner/manager of any place, then you can, of course, take control of your page and add relevant information other visitors might want to know